Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Preliminary effects of oral ANS-6637, an ALDH2 inhibitor, on cue-induced craving, safety and alcohol consumption among adults with alcohol use disorder: a proof-of-concept, randomized, human laboratory trial.
Journal: Alcohol and alcoholism (Oxford, Oxfordshire)
Published: August 19, 2024
A Randomized Controlled Trial of Medial Prefrontal Cortex Theta Burst Stimulation for Cocaine Use Disorder: A Three-Month Feasibility and Brain Target Engagement Study.
Journal: Biological psychiatry. Cognitive neuroscience and neuroimaging
Published: July 03, 2024
Sleep as an Important Target or Modifier in Alcohol Use Disorder Clinical Treatment: Example From a Recent Gabapentin Randomized Clinical Trial.
Journal: Journal of addiction medicine
Published: June 03, 2024
Effects of pharmacological and genetic regulation of COMT activity in alcohol use disorder: a randomized, placebo-controlled trial of tolcapone.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: March 07, 2022
Medial Prefrontal Cortex Theta Burst Stimulation Improves Treatment Outcomes in Alcohol Use Disorder: A Double-Blind, Sham-Controlled Neuroimaging Study.
Journal: Biological psychiatry global open science
Published: October 29, 2021
Effects of Gabapentin on Dorsal Anterior Cingulate Cortex GABA and Glutamate Levels and Their Associations With Abstinence in Alcohol Use Disorder: A Randomized Clinical Trial.
Journal: The American journal of psychiatry
Published: July 14, 2021
Sleep and substance use disorder treatment: A preliminary study of subjective and objective assessment of sleep during an intensive outpatient program.
Journal: The American journal on addictions
Published: January 24, 2021
The Drug Abuse Research Training (DART) Program for Psychiatry Residents and Summer Fellows: 15-Year Outcomes.
Journal: Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry
Published: December 03, 2020
Opioid and Dopamine Genes Interact to Predict Naltrexone Response in a Randomized Alcohol Use Disorder Clinical Trial.
Journal: Alcoholism, clinical and experimental research
Published: April 10, 2020
Efficacy of Gabapentin for the Treatment of Alcohol Use Disorder in Patients With Alcohol Withdrawal Symptoms: A Randomized Clinical Trial.
Journal: JAMA internal medicine
Published: March 10, 2020
Insomnia severity during early abstinence is related to substance use treatment completion in adults enrolled in an intensive outpatient program.
Journal: Journal of substance abuse treatment
Published: January 17, 2019
Last Updated: 09/26/2026